3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
NIH
1
INDUSTRY
1
Study Type
Observational
1
Sponsor
Cancer Type
Thoracic
1
Sarcoma
1
Plasma cell
1
Other solid neoplasm
1
Other hematologic neoplasm
1
NET
1
Myeloid
1
Lymphoid
1
Head & Neck
1
Gynecologic
1
Genitourinary
1
Gastrointestinal
1
Endocrine
1
Dermatologic
1
CNS
1
Breast
1
Conditions
Waldenstrom Macroglobulinemia
1
Vulvar Neoplasms
1
Vaginal Neoplasms
1
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Ureteral Neoplasms
1
Tongue Neoplasms
1
Thyroid Neoplasms
1
Thymus Neoplasms
1
Testicular Neoplasms
1
Stomach Neoplasms
1
Skin Neoplasms
1
Sarcoma, Synovial
1
Sarcoma, Kaposi
1
Sarcoma
1
Salivary Gland Neoplasms
1
Rectal Neoplasms
1
Prostatic Neoplasms
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pheochromocytoma
1
Pharyngeal Neoplasms
1
Penile Neoplasms
1
Parotid Neoplasms
1
Parathyroid Neoplasms
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Osteosarcoma
1
Neuroendocrine Tumors
1
Neoplasms, Unknown Primary
1
Interventions
Doxorubicin
44
Imatinib Mesylate
33
pembrolizumab
23
Cyclophosphamide
23
Sunitinib
22
Gemcitabine
22
Temozolomide
17
Irinotecan
14
Bevacizumab
14
Docetaxel
13
nilotinib
12
Trabectedin
12
ripretinib
11
pazopanib
11
olaratumab
10
fludarabine
10
eribulin
10
regorafenib
9
avapritinib
9
Fluorouracil
9
Carboplatin
9
Paclitaxel
8
Nivolumab
8
Ifosfamide
8
Ibandronic Acid
8
spartalizumab
7
anlotinib
7
Vincristine
7
Radiation
7
Ipilimumab
7
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
INDUSTRY
×
Molecular Diagnostic Techniques
×
Sarcoma
×
Clear all
NCT04028479
2024-12-18
ROOT
Taproot Health
Completed
167 enrolled